Effect of supplementation in treatment of women with polycystic ovary syndrome

Phase 3

Completed

• Conditions: E28.2; Polycystic ovary syndrome.; Polycystic ovarian syndrome

• Registration Number: IRCT201601025623N62
• Lead Sponsor: Vice chancellor for research, Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 70

Inclusion Criteria

Patients with PCOS according to Rotterdam criteria
Aged 18 to 40 years

Exclusion Criteria

Pregnant women
Elevated levels of prolactin
Thyroid disorder
Endocrine diseases including diabetes or impaired glucose tolerance, and gastrointestinal problems

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Questionnaire.;Testosterone. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.